Trading / Browse Companies / Biomeme stock

Biomeme Stock

biomeme.comBioTechFounded: 2012Funding to Date: $12.87MM

Biomeme is the developer of a platform that transforms your smartphone into a mobile lab for advanced DNA diagnostics and real-time disease surveillance.

Buy or sell Biomeme stock
OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Biomeme, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Max Perelman
Co-Founder, President, Business Lead and Chief Executive Officer
Jesse vanWestrienen
Co-Founder & Lead Biologist
Marc DeJohn
Co-founder & Lead Engineer

Other companies like Biomeme in the BioTech sector

Mammoth Biosciences
Sector
BioTech
Last Round Est. Valuation
$1.08B
Ginkgo Bioworks
Sector
BioTech
Last Round Est. Valuation
$4.89B
PROCEPT BioRobotics
Sector
BioTech
Last Round Est. Valuation
$872.62MM
Synthego
Sector
BioTech
Last Round Est. Valuation
$486.63MM
eFFECTOR Therapeutics
Sector
BioTech
Last Round Est. Valuation
$186.12MM
Human Longevity
Sector
BioTech
Last Round Est. Valuation
$50.4MM
Grail
Sector
BioTech
Last Round Est. Valuation
$4.26B
Arsenal Biosciences
Sector
BioTech
Last Round Est. Valuation
$185MM
Caris Life Sciences
Sector
BioTech
 
 

Trending Companies

Frequently Asked Questions